| Authors: |
Zhu X; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Alvarez EA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California., Umetsu SE; Department of Pathology, University of California, San Francisco, San Francisco, California., Chapman JS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California., Chen LM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California., Ueda S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California., Henderson S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Nguyen P; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Calabrese S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Russell J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Aguilar J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Smith SA; AstraZeneca (United Kingdom) , Cambridge, United Kingdom., Shah N; AstraZeneca (United Kingdom) , Cambridge, United Kingdom., Feeney L; AstraZeneca (United Kingdom) , Cambridge, United Kingdom., Van Ziffle J; Genomic Medicine Laboratory, University of California, San Francisco, San Francisco, California.; Institute for Human Genetics, University of California, San Francisco, San Francisco, California., Turski ML; Molecular Oncology Initiative, University of California, San Francisco, San Francisco, California., Ko AH; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Munster PN; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Ashworth A; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Collisson EA; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Aggarwal RR; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. |
